Your browser doesn't support javascript.
loading
Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinoma.
Zheng, Chunxing; Snow, Bryan E; Elia, Andrew J; Nechanitzky, Robert; Dominguez-Brauer, Carmen; Liu, Shaofeng; Tong, Yin; Cox, Maureen A; Focaccia, Enrico; Wakeham, Andrew C; Haight, Jillian; Tobin, Chantal; Hodgson, Kelsey; Gill, Kyle T; Ma, Wei; Berger, Thorsten; Heikenwälder, Mathias; Saunders, Mary E; Fortin, Jerome; Leung, Suet Yi; Mak, Tak W.
Afiliación
  • Zheng C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Snow BE; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong SAR, China.
  • Elia AJ; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Nechanitzky R; Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Dominguez-Brauer C; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Liu S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Tong Y; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Cox MA; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong SAR, China.
  • Focaccia E; Department of Pathology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China.
  • Wakeham AC; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Haight J; Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Tobin C; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hodgson K; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Gill KT; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Ma W; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Berger T; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Heikenwälder M; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Saunders ME; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Fortin J; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Leung SY; Division of Chronic Inflammation and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Mak TW; The M3 Research Center, Medical Faculty Tübingen, Tübingen, Germany.
Nat Cancer ; 4(10): 1437-1454, 2023 Oct.
Article en En | MEDLINE | ID: mdl-37640929
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Risk_factors_studies Límite: Animals Idioma: En Revista: Nat Cancer Año: 2023 Tipo del documento: Article País de afiliación: Canadá